Diabetes Care 28:2289-2304, 2005
© 2005 by the American Diabetes Association, Inc.
Reviews/Commentaries/ADA Statements ADA Statement |
The Metabolic Syndrome: Time for a Critical Appraisal
Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes
Richard Kahn, PHD1,
John Buse, MD, PHD2,
Ele Ferrannini, MD3 and
Michael Stern, MD4
1 American Diabetes Association, Alexandria, Virginia
2 Division of Endocrinology and of General Medicine & Clinical Epidemiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina
3 Department of Internal Medicine, University of Pisa School of Medicine, Pisa, Italy
4 Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas
Address correspondence and reprint requests to Richard Kahn, PhD, American Diabetes Association, 1701 N. Beauregard St., Alexandria, VA 22311. E-mail: rkahn{at}diabetes.org
ABSTRACT
The term "metabolic syndrome" refers to a clustering of specific cardiovascular disease (CVD) risk factors whose underlying pathophysiology is thought to be related to insulin resistance. Since the term is widely used in research and clinical practice, we undertook an extensive review of the literature in relation to the syndromes definition, underlying pathogenesis, and association with CVD and to the goals and impact of treatment. While there is no question that certain CVD risk factors are prone to cluster, we found that the metabolic syndrome has been imprecisely defined, there is a lack of certainty regarding its pathogenesis, and there is considerable doubt regarding its value as a CVD risk marker. Our analysis indicates that too much critically important information is missing to warrant its designation as a "syndrome." Until much needed research is completed, clinicians should evaluate and treat all CVD risk factors without regard to whether a patient meets the criteria for diagnosis of the "metabolic syndrome."
Abbreviations: ATP III, Third Report of the National Cholesterol Education Programs Adult Treatment Panel CHD, coronary heart disease CRP, C-reactive protein CVD, cardiovascular disease IFG, impaired fasting glucose IGT, impaired glucose tolerance IMT, intimal-medial thickness WHO, World Health Organization

CiteULike Del.icio.us Digg Reddit Technorati What's this?
Related Article:
-
POSITION STATEMENTS & ADA STATEMENTS
Diabetes Care 2006 29: S75-S77.
[Extract]
[Full Text]
[PDF]
This article has been cited by other articles:

|
 |

|
 |
 
S.H. Song
Physical activity in the elderly--it is never too late!
QJM,
September 1, 2008;
101(9):
743 - 744.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Ness-Abramof and C. M. Apovian
Waist Circumference Measurement in Clinical Practice
Nutr Clin Pract,
August 1, 2008;
23(4):
397 - 404.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K.-T. Li, B. C.-H. Kwan, C. C. Szeto, and G. T.-C. Ko
Metabolic syndrome in peritoneal dialysis patients
NDT Plus,
August 1, 2008;
1(4):
206 - 214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Grunfeld, D. P. Kotler, D. K. Arnett, J. M. Falutz, S. M. Haffner, P. Hruz, H. Masur, J. B. Meigs, K. Mulligan, P. Reiss, et al.
Contribution of Metabolic and Anthropometric Abnormalities to Cardiovascular Disease Risk Factors
Circulation,
July 8, 2008;
118(2):
e20 - e28.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Steele, S. Brage, K. Corder, N. J. Wareham, and U. Ekelund
Physical activity, cardiorespiratory fitness, and the metabolic syndrome in youth
J Appl Physiol,
July 1, 2008;
105(1):
342 - 351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S.H. Song and C.A. Hardisty
Diagnosing metabolic syndrome in type 2 diabetes: does it matter?
QJM,
June 1, 2008;
101(6):
487 - 491.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.P. Cheung, R.C.W. Ma, P.M. Lam, I.H. Lok, C.J. Haines, W.Y. So, P.C.Y. Tong, C.S. Cockram, C.C. Chow, and W.B. Goggins
Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome
Hum. Reprod.,
June 1, 2008;
23(6):
1431 - 1438.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Taylor, J. Liu, G. Wilson, S. H. Golden, E. Crook, C. D. Brunson, M. Steffes, W. D. Johnson, and J. H. Sung
Distinct Component Profiles and High Risk Among African Americans With Metabolic Syndrome: The Jackson Heart Study
Diabetes Care,
June 1, 2008;
31(6):
1248 - 1253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Despres, I. Lemieux, J. Bergeron, P. Pibarot, P. Mathieu, E. Larose, J. Rodes-Cabau, O. F. Bertrand, and P. Poirier
Abdominal Obesity and the Metabolic Syndrome: Contribution to Global Cardiometabolic Risk
Arterioscler. Thromb. Vasc. Biol.,
June 1, 2008;
28(6):
1039 - 1049.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Mozaffarian, A. Kamineni, R. J. Prineas, and D. S. Siscovick
Metabolic Syndrome and Mortality in Older Adults: The Cardiovascular Health Study
Arch Intern Med,
May 12, 2008;
168(9):
969 - 978.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus Conference Report From the American Diabetes Association and the American College of Cardiology Foundation
J. Am. Coll. Cardiol.,
April 15, 2008;
51(15):
1512 - 1524.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Brunzell, M. Davidson, C. D. Furberg, R. B. Goldberg, B. V. Howard, J. H. Stein, and J. L. Witztum
Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation
Diabetes Care,
April 1, 2008;
31(4):
811 - 822.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Grundy
Metabolic Syndrome Pandemic
Arterioscler. Thromb. Vasc. Biol.,
April 1, 2008;
28(4):
629 - 636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kurth and G. Logroscino
The Metabolic Syndrome: More Than the Sum of Its Components?
Stroke,
April 1, 2008;
39(4):
1068 - 1069.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K G M M Alberti and P Z Zimmet
Should we dump the metabolic syndrome? No
BMJ,
March 22, 2008;
336(7645):
641 - 641.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Jackson
Gender differences in cardiovascular disease prevention
Menopause Int,
March 1, 2008;
14(1):
13 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Despres and H. B. Brewer
Metabolic syndrome: the dysmetabolic state of dysfunctional adipose tissue and insulin resistance
Eur. Heart J. Suppl.,
March 1, 2008;
10(suppl_B):
B1 - B3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Grundy
A changing paradigm for prevention of cardiovascular disease: emergence of the metabolic syndrome as a multiplex risk factor
Eur. Heart J. Suppl.,
March 1, 2008;
10(suppl_B):
B16 - B23.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Despres, P. Poirier, J. Bergeron, A. Tremblay, I. Lemieux, and N. Almeras
From individual risk factors and the metabolic syndrome to global cardiometabolic risk
Eur. Heart J. Suppl.,
March 1, 2008;
10(suppl_B):
B24 - B33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. B. Haas
The Role of the Diabetes Educator: Patient Case Scenarios
The Diabetes Educator,
March 1, 2008;
34(Supplement_2):
32S - 36S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hollander
Cardiometabolic Risk Factors and Visceral Adipose Tissue
The Diabetes Educator,
March 1, 2008;
34(Supplement_2):
37S - 41S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. T. Boyd
Management Through Risk Factor Modification
The Diabetes Educator,
March 1, 2008;
34(Supplement_2):
42S - 48S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. de Wilde, R. Mohren, S. van den Berg, M. Boekschoten, K. W.-V. Dijk, P. de Groot, M. Muller, E. Mariman, and E. Smit
Short-term high fat-feeding results in morphological and metabolic adaptations in the skeletal muscle of C57BL/6J mice
Physiol Genomics,
February 19, 2008;
32(3):
360 - 369.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Bianchi, R. Miccoli, G. Penno, and S. Del Prato
Primary Prevention of Cardiovascular Disease in People With Dysglycemia
Diabetes Care,
February 1, 2008;
31(Supplement_2):
S208 - S214.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. P F Dullaart, A. K Groen, G. M Dallinga-Thie, R. de Vries, W. J Sluiter, and A. van Tol
Fibroblast cholesterol efflux to plasma from metabolic syndrome subjects is not defective despite low high-density lipoprotein cholesterol
Eur. J. Endocrinol.,
January 1, 2008;
158(1):
53 - 60.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. S. Fenton and M. R. Chavez
Medication-Induced Weight Gain and Dyslipidemia in Patients With Schizophrenia
Focus,
January 1, 2008;
6(2):
246 - 253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Berglund, M. Lefevre, H. N Ginsberg, P. M Kris-Etherton, P. J Elmer, P. W Stewart, A. Ershow, T. A Pearson, B. H Dennis, P. S Roheim, et al.
Comparison of monounsaturated fat with carbohydrates as a replacement for saturated fat in subjects with a high metabolic risk profile: studies in the fasting and postprandial states
Am. J. Clinical Nutrition,
December 1, 2007;
86(6):
1611 - 1620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Matheson
From Syndrome to Spectrum: What Evolution Suggests about the Status of the Metabolic Syndrome
Clin. Chem.,
December 1, 2007;
53(12):
2218 - 2219.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Wu, J. K. Collins, P. Perkins-Veazie, M. Siddiq, K. D. Dolan, K. A. Kelly, C. L. Heaps, and C. J. Meininger
Dietary Supplementation with Watermelon Pomace Juice Enhances Arginine Availability and Ameliorates the Metabolic Syndrome in Zucker Diabetic Fatty Rats
J. Nutr.,
December 1, 2007;
137(12):
2680 - 2685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D Gluckman
Evolving a definition of disease
Arch. Dis. Child.,
December 1, 2007;
92(12):
1053 - 1054.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Reinehr, G. de Sousa, A. M. Toschke, and W. Andler
Comparison of metabolic syndrome prevalence using eight different definitions: a critical approach
Arch. Dis. Child.,
December 1, 2007;
92(12):
1067 - 1072.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Cull, C. C. Jensen, R. Retnakaran, and R. R. Holman
Impact of the Metabolic Syndrome on Macrovascular and Microvascular Outcomes in Type 2 Diabetes Mellitus: United Kingdom Prospective Diabetes Study 78
Circulation,
November 6, 2007;
116(19):
2119 - 2126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. S. Jarboe
Considering the Impact on Overall Patient Health When Choosing Antipsychotic Therapy
Journal of the American Psychiatric Nurses Association,
November 1, 2007;
13(5_suppl):
S23 - S28.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Schindler
Review: The metabolic syndrome as an endocrine disease: is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis?
Therapeutic Advances in Cardiovascular Disease,
October 1, 2007;
1(1):
7 - 26.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Margozzini, A. Rigotti, C. Ferreccio, N. Quezada, M. Garrido, and G. Valdes
Review: Hypertension and the cardiometabolic syndrome in Chile: a review of concepts and consequences for the developing world
Therapeutic Advances in Cardiovascular Disease,
October 1, 2007;
1(1):
83 - 90.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Korantzopoulos, M. Elisaf, and H. J. Milionis
Multifactorial intervention in metabolic syndrome targeting at prevention of chronic kidney disease ready for prime time?
Nephrol. Dial. Transplant.,
October 1, 2007;
22(10):
2768 - 2774.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. G. Dik, C. Jonker, H. C. Comijs, D. J.H. Deeg, A. Kok, K. Yaffe, and B. W. Penninx
Contribution of Metabolic Syndrome Components to Cognition in Older Individuals
Diabetes Care,
October 1, 2007;
30(10):
2655 - 2660.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. H. Curtis, B. G. Hammill, M. A. Bethel, K. J. Anstrom, J. S. Gottdiener, and K. A. Schulman
Costs of the Metabolic Syndrome in Elderly Individuals: Findings from the Cardiovascular Health Study
Diabetes Care,
October 1, 2007;
30(10):
2553 - 2558.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. F. Lien, A. J. Brown, J. D. Ard, C. Loria, T. P. Erlinger, A. C. Feldstein, P.-H. Lin, C. M. Champagne, A. C. King, H. L. McGuire, et al.
Effects of PREMIER Lifestyle Modifications on Participants With and Without the Metabolic Syndrome
Hypertension,
October 1, 2007;
50(4):
609 - 616.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. van den Berg, G. J. Biessels, A. J.M de Craen, J. Gussekloo, and R.G.J. Westendorp
The metabolic syndrome is associated with decelerated cognitive decline in the oldest old
Neurology,
September 4, 2007;
69(10):
979 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Zornitzki, O. Ayzenberg, G. Gandelman, S. Vered, E. Yaskil, D. Faraggi, A. Caspi, S. Goland, O. Shvez, A. Schattner, et al.
Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women
QJM,
September 1, 2007;
100(9):
575 - 581.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ritz
Metabolic Syndrome: An Emerging Threat to Renal Function
Clin. J. Am. Soc. Nephrol.,
September 1, 2007;
2(5):
869 - 871.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Ingelsson, M. J. Pencina, G. H. Tofler, E. J. Benjamin, K. J. Lanier, P. F. Jacques, C. S. Fox, J. B. Meigs, D. Levy, M. G. Larson, et al.
Multimarker Approach to Evaluate the Incidence of the Metabolic Syndrome and Longitudinal Changes in Metabolic Risk Factors: The Framingham Offspring Study
Circulation,
August 28, 2007;
116(9):
984 - 992.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Tanomsup, W. Aekplakorn, P. Sritara, M. Woodward, S. Yamwong, S. Tunlayadechanont, A. Tatsaneeyapan, S. Lim, and R. Rajatanavin
A Comparison Of Components of Two Definitions of the Metabolic Syndrome Related to Cardiovascular Disease and All-Cause Mortality in a Cohort Study in Thailand
Diabetes Care,
August 1, 2007;
30(8):
2138 - 2140.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Vaidya, M. Szklo, K. Liu, P. J. Schreiner, A. G. Bertoni, and P. Ouyang
Defining the Metabolic Syndrome Construct: Multi-Ethnic Study of Atherosclerosis (MESA) cross-sectional analysis
Diabetes Care,
August 1, 2007;
30(8):
2086 - 2090.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dhingra, L. Sullivan, P. F. Jacques, T. J. Wang, C. S. Fox, J. B. Meigs, R. B. D'Agostino, J. M. Gaziano, and R. S. Vasan
Soft Drink Consumption and Risk of Developing Cardiometabolic Risk Factors and the Metabolic Syndrome in Middle-Aged Adults in the Community
Circulation,
July 31, 2007;
116(5):
480 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Matfin
Review: Challenges in developing therapies for the metabolic syndrome
The British Journal of Diabetes & Vascular Disease,
July 1, 2007;
7(4):
152 - 156.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Blaum, N. A. West, and M. N. Haan
Is the Metabolic Syndrome, With or Without Diabetes, Associated With Progressive Disability in Older Mexican Americans?
J. Gerontol. A Biol. Sci. Med. Sci.,
July 1, 2007;
62(7):
766 - 773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. de Simone, R. B. Devereux, M. Chinali, L. G. Best, E. T. Lee, J. M. Galloway, H. E. Resnick, and for the Strong Heart Study Investigators
Prognostic Impact of Metabolic Syndrome by Different Definitions in a Population With High Prevalence of Obesity and Diabetes: The Strong Heart Study
Diabetes Care,
July 1, 2007;
30(7):
1851 - 1856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Cournil, R. Defay, A. Lacroux, S. Barny, A. Fontbonne, and for the CALDIA Study Group
Paradoxical Relationships Between Anthropometric Variables and Phenotypic Expression of the Metabolic Syndrome in Nondiabetic Polynesians of New Caledonia
Diabetes Care,
July 1, 2007;
30(7):
1909 - 1911.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. F. Arenillas, M. A. Moro, and A. Davalos
The Metabolic Syndrome and Stroke: Potential Treatment Approaches
Stroke,
July 1, 2007;
38(7):
2196 - 2203.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Varon
METABOLIC SYNDROME
J Am Dent Assoc,
June 1, 2007;
138(6):
710 - 711.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. H. Friedlander and J. Weinreb
Authors' response
J Am Dent Assoc,
June 1, 2007;
138(6):
711 - 712.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A.H. Barnett, P. Mackin, I. Chaudhry, A. Farooqi, R. Gadsby, A. Heald, J. Hill, H. Millar, R. Peveler, A. Rees, et al.
Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia
J Psychopharmacol,
June 1, 2007;
21(4):
357 - 373.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. M. Reaven
The Individual Components of the Metabolic Syndrome: Is There a Raison d'Etre?
J. Am. Coll. Nutr.,
June 1, 2007;
26(3):
191 - 195.
| |